UK Clinical Trial Recruitment: Industry-Sponsored Participation Declines
UK Clinical Trial Recruitment Continues to Decline
Patient participation in industry-sponsored clinical trials in the UK has fallen for a fifth consecutive year, according to the supplied report. The decline contrasts with improvements in clinical trial participation elsewhere.
What the report says
- Recruitment to industry-sponsored trials in the UK has decreased for five years in a row.
- Participation has improved elsewhere, although the report provides no locations, figures, or comparisons.
- No causes, affected therapeutic areas, or implications for individual studies are specified.
Why the trend matters
Recruitment is central to clinical research: delays in enrolling participants can affect study timelines and the generation of evidence. The information available here does not establish why UK recruitment has fallen or how the trend is affecting specific trials.
Consult the original report for additional data, analysis, and context.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.